glp 1 and creatine GLP-1 Use in Non-Diabetics Associated with Trivial Increase in Creatinine Creatine for GLP-1 Users: Science-Backed

It can help fade them over time, but it works better as a systemic brightener than a spot treatment

Use is off-label and administered under medical supervision for research and therapeutic purposes

Therapeutic Research Protocol Dose: 5 10 mg (variant 10 mg pen = 100200 clicks) Duration: 4 6 weeks loading, then taper Frequency: Split into 2 3 weekly injections Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose protocol used in connective tissue and musculoskeletal injury models

Tuy nhin, nu tiu th qu nhiu protein, c th c th gp kh khn trong vic chuyn ha v loi b cht thi protein qua thn, c bit i vi ngi c vn v thn

Taweesedt PT, Orakpo N, Pelayo R